Friday, 03 July 2015

Comvita Limited

NZX : CVT

4.400
03 Jul 15 10:00
Change:
 0.00
Open:
4.400
High:
4.400
Ask:
4.400
Volume:
12,565
Change(%):
0.00
Prev:
4.400
Low:
4.400
Bid:
4.350
Avg vol:
0
Profile
Comvita Limited engages in the manufacture and marketing of natural health products. The company offers functional food, health care, personal care, and medical products. Its product portfolio includes antioxidants, apple cider vinegar, bee pollen, colostrum, honey, herbal extracts, manuka honey, nutritional oil, olive leaf complex, propolis, royal jelly, skincare, winter wellness, and wound care products. The company operates primarily in New Zealand, Australia, Asia, North America, the United Kingdom, and rest of Europe. Comvita Limited was founded in 1974 and is based in Te Puke, New Zealand.
Summary
Shares:39,580,610
Issuer:Comvita Limited
Solicitor:Sharp Tudhope
Registry:LINK MARKET SERVICES LIMITED
Auditor:KPMG Tauranga
Settlement:NZCDC Settlement System
Website:http://www.comvita.com/
Fundamentals
Market Cap:$174,154,684
52 wk High:4.420
52 wk Low:3.490
Sector:Consumer
Div/Yield:5.710
EPS:0.041
Price/Earnings:36.790
NTA:0.645
Address
Comvita Limited
Wilson Road South
Paengaroa
Te Puke,
New Zealand
Latest News
  • Analyst Price Target Update on Derma Sciences, Inc.

    00:33 | 3/7/15
    The Daily Rover
    ... home health care agencies and physicians offices. Some of its products are sold through retail channels. Effective September 4, 2013, Derma Sciences Inc acquired a 7.3% stake in Comvita Ltd, a manufacturer and wholesaler of natural health products. more»
  • Derma Sciences, Inc. Short Interest Update

    14:26 | 27/6/15
    The Daily Rover
    ... home health care agencies and physicians offices. Some of its products are sold through retail channels. Effective September 4, 2013, Derma Sciences Inc acquired a 7.3% stake in Comvita Ltd, a manufacturer and wholesaler of natural health products. more»
  • Derma Sciences, Inc. (NASDAQ:DSCI) Stock Rating Update

    08:15 | 26/6/15
    Investor Newswire
    Derma Sciences, Inc. (NASDAQ:DSCI) has been issued a 1.67 rating by the sell-side brokerage firms covering the stock. Basing the rating on a simplified scale where 1 represents a Buy and 5 represents a Sell, this is the average rating based on the 3 ... more»
  • Company Shares of Derma Sciences, Inc. Rally 9.02%

    15:22 | 22/6/15
    The Daily Rover
    ... home health care agencies and physicians offices. Some of its products are sold through retail channels. Effective September 4, 2013, Derma Sciences Inc acquired a 7.3% stake in Comvita Ltd, a manufacturer and wholesaler of natural health products. more»
  • Derma Sciences, Inc. (DSCI) Discloses Form 4 Insider Selling : Exec. Brett ...

    01:52 | 21/6/15
    OTC Outlook
    ... home health care agencies and physicians' offices. Some of its products are sold through retail channels. Effective September 4, 2013, Derma Sciences Inc acquired a 7.3% stake in Comvita Ltd, a manufacturer and wholesaler of natural health products. more»
Announcements
There are currently no comments on this topic.
Be the first person to Add a Comment...
Add a Comment
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
Global Indices
CodeLastChange
NZ5058,40952,568899.90%
COMP5,00940.08%
DJI17,730280.16%
SP5002,07710.03%
DAX11,099810.73%
FTSE6,630220.33%
NI22520,5231930.95%
TWI71.390.320.45%
Currencies
CodeLastChange
EURUSD1.1080.0040.35%
NZDUSD0.67200.00120.18%
AUDUSD0.76330.00040.05%
NZDAUD0.87980.00150.17%